Paradromics

📍 Austin, United States🗓 Founded 2015👥 102 employees💰 Last funded Jun 2025
Biotechnology Research🌐 paradromics.com
Website LinkedIn
ENABLING NEUROTECHNOLOGY Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments. THE MISSION Data-driven BCI-based technologies for brain health Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions. ABOUT Matt Angle Ph.D. (CEO) founded Paradromics to build a high-data-rate BCI platform capable of addressing critical unmet clinical needs. With early funding from the NIH and DARPA, the company developed its core neurotechnology and, by 2019, shifted focus to its first product: the Connexus® BCI.   Connexus is designed to restore communication through text, synthesized speech, and computer control for people with severe motor impairments, including those caused by ALS, stroke, or spinal cord injury. Backed by two FDA Breakthrough Device Designations and a successful first-in-human recording in May 2025, Paradromics is now preparing to launch a clinical trial in late 2025 to evaluate the long-term safety and participant benefits of their first product, the Connexus BCI.
12
Total investors
1
Early stage
1
Mid stage
10
Late stage
2015
Founded

Investors

12 investors
All
Early stage
Mid stage
Late stage
Angel investors· 1
Vikram Aditya
Vikram Aditya
Enterprise AI & SaaS GTM leader | Building Magnus (longevity, travel) | 2X Founder, Raised $5M, returned capital | Ex- Sprinklr, DaoLens, Crunch, Brelo (enterprise digital twin), Merkle Science | Angel Investor
Angel Investor
late stage
36 investments
Sep 2023
Early stage· 1
Lu Zhang
Lu Zhang
Founder & Managing Partner at Fusion Fund | Serial Entrepreneur & Board Member | Young Global Leader with WEF (Davos) | Instructor at Stanford
early stage
51 investments
Jan 2016
Mid stage· 1
Enke Bashllari, Ph.D.
Enke Bashllari, Ph.D.
Health & Bio Investor
mid stage
24 investments
Feb 2018
Late stage· 9
MA
Mohammed Al-Abdullah
Founder
late stage
19 investments
Jun 2025
Max Curnin
Max Curnin
Angel investor since 2015 · ~45 companies · 7x · Executive Chairman, Accords
late stage
33 investments
May 2025
Ariane Tom, PhD
Ariane Tom, PhD
Pioneering Neurotech and AI Investments | Founder & Managing Director, Kaleida Capital | Stanford | Milken YLC
late stage
10 investments
Jan 2025
Dennis Kogan
Dennis Kogan
Founder at StorylineCap | Founder at Caresyntax
late stage
2 investments
Jul 2024
Nouf A.
Nouf A.
Managing partner
late stage
18 investments
Jun 2022
Sergio Escoté
Sergio Escoté
Founder & CEO @ optima | Forbes 30 Under 30 | FT1000 Europe’s Fastest Growing Companies | Investor in AI, Longevity & Frontier Tech
late stage
11 investments
2022
Erman Turan
Erman Turan
Founding Managing Partner @3dots
late stage
21 investments
Jul 2021
Daren Martin
Daren Martin
WSJ & USA Today Bestselling Author | Global Speaker | Executive Coach | C-Suite Advisor | Global Company Culture Association Founder
Early Round Investor in Paradromics
late stage
Jun 2021
Krish W. Ramadurai
Krish W. Ramadurai
Partner at AIX Ventures | Author
late stage
51 investments
Mar 2021
Investor geography4 countries
United States
8
Saudi Arabia
2
Turkey
1
Spain
1
Investor activity2016–2025 · investors recorded per year
20161201812021320222202312024120253
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Paradromics?
Paradromics has 12 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 10 late-stage investors.
When did Paradromics last raise funding?
The most recent investment in Paradromics recorded on gritt.io was in June 2025.
When was Paradromics founded?
Paradromics was founded in 2015.
What industry is Paradromics in?
Paradromics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Paradromics based?
Paradromics is headquartered in Austin, United States.